Complications after hematopoietic stem cell transplantationNews & Research
16 curated articles for Complications after hematopoietic stem cell transplantation — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.
- Transplantation and cellular therapy May 10, 2026
Secondary Malignancies after Hematopoietic Stem Cell Transplantation.
Secondary malignancies (SM) are a well-recognized long-term complication after hematopoietic cell transplantation (HCT), increasingly contributing to morbidity and mortality as post-transplant survival improves. However, the incidence, spectrum, and outcomes of SM remain incompletely defined in the ...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Frontiers in immunology May 8, 2026
Pediatric diamond-blackfan anemia after hematopoietic stem cell transplantation complicated by bronchiolitis obliterans and air-leak syndrome leading to lung transplantation: a case report with multimodal follow-up.
Bronchiolitis obliterans syndrome (BOS) is a severe, often fatal pulmonary manifestation of chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplantation (HSCT). Its progression to air-leak syndrome (ALS) signifies a critical deterioration with exceedingly hi...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- NPJ digital medicine May 6, 2026
AI Guided Parenteral Nutrition Therapy After Hematopoietic Stem Cell Transplantation.
Adults undergoing hematopoietic cell transplantation often develop serious complications that cause rapid nutritional decline. We developed and evaluated an AI approach to standardize intravenous nutrition (total parenteral nutrition, TPN) during this vulnerable period. Using real-world records from...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Journal of pharmaceutical health care and sciences May 2, 2026
Personalized tacrolimus therapy in allogeneic hematopoietic stem cell transplantation: from pharmacokinetic variability to novel control strategies.
Allogeneic hematopoietic stem cell transplantation is an established curative therapy for many hematological diseases, but graft-versus-host disease remains a major cause of morbidity and mortality. Tacrolimus, a calcineurin inhibitor, is widely used for prophylaxis because it suppresses T-cell acti...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Transplantation and cellular therapy Apr 8, 2026
A Significant Risk Factor for Post-Transplant Lymphoproliferative Disorder in Pediatric Recipients: Low CD3+CD4+ T Cell Count at 30 Days after Hematopoietic Stem Cell Transplantation.
Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening complication that arises early after pediatric hematopoietic stem cell transplantation (HSCT), primarily due to post-transplant immunosuppression. However, there is still a lack of effective predictive factors for ...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Frontiers in medicine Apr 6, 2026
Development and effectiveness evaluation of a mobile health-based follow-up management model for patients after hematopoietic stem cell transplantation.
To evaluate the association between mobile health (mHealth)-based follow-up and quality of life, self-management capacity, and complication control in patients after hematopoietic stem cell transplantation (HSCT). This retrospective single-center cohort study included 310 HSCT recipients (January 20...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Hematology, transfusion and cell therapy Mar 29, 2026
Mineral disorders after hematopoietic stem cell transplantation in patients receiving parenteral nutrition.
Parenteral nutrition is a critical therapeutic approach for patients undergoing hematopoietic stem cell transplantation. However, parenteral nutrition is associated with complications such as mineral disorders. This study evaluated the prevalence of hypophosphatemia, hypokalemia, and hypomagnesemia ...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Transplantation and cellular therapy Mar 29, 2026
Kidney and Blood Pressure Outcomes in Children Surviving at Least 6 Months after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Pediatric hematopoietic stem cell transplantation (HSCT) recipients are at risk of developing kidney and high blood pressure (BP) conditions, but the prevalence of these conditions is unclear. We aimed to evaluate (1) the proportion of patients with late kidney and high BP outcomes after pediatric H...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Pediatric hematology and oncology Mar 15, 2026
Long-Term Health Outcomes in Male Survivors of Childhood Cancer After Hematopoietic Stem Cell Transplantation: A Registry-Based Study.
Late effects are a major concern after pediatric hematopoietic stem cell transplantation (HSCT), but data on health outcomes beyond early adulthood remain scarce. This study assessed long-term morbidity and mortality in one of the earliest childhood cancer cohorts treated with HSCT. The study compri...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- PeerJ Mar 11, 2026
Risk factors for acute kidney injury after hematopoietic stem cell transplantation in children: a single-center retrospective study.
To analyze the clinical characteristics and risk factors of acute kidney injury (AKI) after hematopoietic stem cell transplantation (HCT) in children. The clinical data of children who underwent HCT at our hospital from August 2016 to December 2023 were retrospectively analyzed, including age, sex, ...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Open forum infectious diseases Feb 27, 2026
Clinical Presentation, Risk Factors and Outcome of Non-Tuberculous Mycobacteria Infection in Hematopoietic Stem-Cell Transplantation: A Multinational Case-Control Study.
The clinical and microbiological features of infection due to non-tuberculous mycobacteria (NTM) after hematopoietic stem-cell transplantation (HSCT) remain poorly understood. We performed a retrospective, multinational case-control study that included HSCT recipients (≥12 years) diagnosed wi...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Cell journal Feb 16, 2026
Feasibility and Safety of IL-15-Activated CD56+ Cell Therapy in High-Risk Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: Phase I Clinical Trial.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the most effective treatment for patients with high-risk acute myeloid leukemia (AML), but relapse remains a major challenge. Immunotherapy is considered a promising approach for reducing the risk of relapse. Natural killer (NK) ...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- The Journal of allergy and clinical immunology Feb 6, 2026
Late effects after hematopoietic stem cell transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP, and TCWP EBMT Study.
Hematopoietic stem cell transplantation (HCT) is the only curative treatment in primary hemophagocytic lymphohistiocytosis (pHLH). However, HCT is associated with a wide range of late effects (LEs). We sought to characterize the long-term outcome and LEs following HCT in pHLH. A total of 274 childre...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Seminars in thrombosis and hemostasis Jan 13, 2026
Thrombocytopenia after Hematopoietic Stem Cell Transplantation in Pediatrics and Adults: A Narrative Review Including Etiology, Management, Monitoring, and Novel Therapies.
Thrombocytopenia following hematopoietic stem cell transplantation (HSCT) is a common complication that is associated with a remarkable increase in morbidity and mortality. Post-HSCT thrombocytopenia is a multifactorial condition with several mechanisms, including reduced platelet production in bone...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Immunology letters Jan 8, 2026
Letter to the editor: "Importance of BCG vaccination at birth in pediatric patients with chronic granulomatous disease after hematopoietic stem cell transplantation in developing countries".
Letter to the editor: "Importance of BCG vaccination at birth in pediatric patients with chronic granulomatous disease after hematopoietic stem cell transplantation in developing countries".
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
- Immunology letters Dec 3, 2025
Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries.
Recent advances in hematopoietic stem cell transplantation (HSCT) have improved clinical outcomes; however, various factors continue to influence HSCT success, especially vaccination in immunocompromised patients who receive vaccination at birth. While several studies have investigated the efficacy ...
Why it matters: Recent peer-reviewed research on Complications after hematopoietic stem cell transplantation that may be relevant for patients and caregivers.
More on Complications after hematopoietic stem cell transplantation
Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.